Cannabics Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.08.21	World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors (PR Newswire)
20.07.21	Cannabics Pharmaceuticals Appoints a Second Independent Board Member (PR Newswire)
07.07.21	Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member (PR Newswire)
28.06.21	Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice (PR Newswire)
17.06.21	Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases (PR Newswire)
26.05.20	Cannabics Pharmaceuticals to Capitalize on Israel's Final Approval for the Export of Medical Cannabis (PR Newswire)
27.01.20	Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit (PR Newswire)
28.08.18	Cannabics Pharmaceuticals Inc. Appoints Dr. Estery Giloz-Ran to Its Advisory Board (PR Newswire)
22.05.18	Cannabics Pharmaceuticals Hires Two New Scientists to Further Develop Cannabinoid Diagnostic Tests and Treatments for Cancer (PR Newswire)
28.11.17	Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids (PR Newswire)
25.09.17	Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells (PR Newswire)
06.09.17	Cannabics Pharmaceuticals Files a Patent Application for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs (PR Newswire)
28.08.17	Cannabics Pharmaceuticals Received Positive Report from The Patent Cooperation Treaty Regarding Cannabinoid Personalized Screening of Cancer Cells (PR Newswire)
24.07.17	Cannabics Pharmaceuticals Establishes a Human-Cannabis-Cancer Genetics lab to Expand its Personalized Diagnostics (PR Newswire)
12.07.17	Cannabics Pharmaceuticals Executed a Final Collaboration Agreement with SIMFO GmbH (PR Newswire)
11.07.17	Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
11.07.17	Cannabinoid Market Growth Expands With Rising Influence of Pharma and Biotech Science Advancements (PR Newswire)
30.06.17	Cannabics Pharmaceuticals Receives Positive Results in Drug Sensitivity Tests on CTCs (PR Newswire)
20.06.17	Substantial Expansion in Cannabis Operations and Grow Facilities in North America Leading to Increased Production and Revenues (PR Newswire)
20.06.17	Substantial Expansion in Cannabis Operations and Grow Facilities in North America Leading to Increased Production and Revenues (PR Newswire)
02.06.17	Cannabics Pharmaceuticals Inc. Provides Shareholders Update June 2017 (PR Newswire)
02.06.17	Cannabics Pharmaceuticals Inc. Provides Shareholders Update June 2107 (PR Newswire)
10.05.17	Cannabics Pharmaceuticals Raises $3,000,000 in Capital Raise Transaction (PR Newswire)
03.05.17	Cannabics Pharmaceuticals Announces Scientific Collaboration With A Leading CTC European Lab (PR Newswire)
03.04.17	Cannabics Pharmaceuticals Inc. Receives the Final Report of Its Research on Antitumor Properties of Cannabinoids Held in Israel (PR Newswire)
03.04.17	Cannabics Pharmaceuticals Inc. Receives the Final Report of Its Research on Antitumor Properties of Cannabinoids Held in Israel (PR Newswire)
21.03.17	Medicinal Cannabis Applications Target the Development of Enhanced Therapies and Treatments for Various Health Disorders (PR Newswire)
21.03.17	Medicinal Cannabis Applications Target the Development of Enhanced Therapies and Treatments for Various Health Disorders (PR Newswire)
09.03.17	Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors (PR Newswire)
23.02.17	Cannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares (PR Newswire)
22.02.17	Cannabis Product Development for Cannabinoid CBD - THC Oil Formulas Leading to Higher Quality Medicinal Marijuana Therapies (PR Newswire)
22.02.17	Cannabis Product Development for Cannabinoid CBD - THC Oil Formulas Leading to Higher Quality Medicinal Marijuana Therapies (PR Newswire)
21.02.17	Pure Cannabis Concentrate & CBD Oil Product Demand Escalates in Legal Marijuana Market (PR Newswire)
21.02.17	Pure Cannabis Concentrate & CBD Oil Product Demand Escalates in Legal Marijuana Market (PR Newswire)
17.02.17	Americans' Favorable Outlook on the Cannabis Market (PR Newswire)
14.02.17	Breakthroughs in Cannabinoid (CBD) Therapies and Oral Products Prompting Optimism in Medicinal Marijuana Growth (PR Newswire)
14.02.17	Breakthroughs in Cannabinoid (CBD) Therapies and Oral Products Prompting Optimism in Medicinal Marijuana Growth (PR Newswire)
08.02.17	Israeli Innovation is at the Heart of a Growing Cannabis Ecosystem (PR Newswire)
08.02.17	Cannabis Asset Expansions and Acquisitions Quickly Becoming Catalyst For Exploding Marijuana Industry Growth (PR Newswire)
08.02.17	Cannabis Asset Expansions and Acquisitions Quickly Becoming Catalyst For Exploding Marijuana Industry Growth (PR Newswire)
07.02.17	Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients (PR Newswire)
01.02.17	FinancialBuzz.com: Macroeconomic Events May Benefit Small Caps (PR Newswire)
03.01.17	Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome (PR Newswire)
05.12.16	Capital Infusion into Cannabis Industry Operations for Product Development and Acquisitions Fueling Major Sector Growth Possibilities (PR Newswire)
02.12.16	The Next Biggest Industry Could Potentially Be Cannabis (PR Newswire)
01.12.16	Cannabics Pharmaceuticals Announces Specific Ratios of Cannabinoids Led to Apoptosis in MDA-MB-231 Breast Cancer Cell Viability (PR Newswire)
29.11.16	Potential Booming of the "Green" Rush (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	30.37	2.88 %	K V
Part Grp Hldg	1’330.00	2.39 %	K V
Roche Hldg G	271.80	1.84 %	K V
Givaudan	3’941.00	1.52 %	K V
Novartis	91.64	0.75 %	K V
Geberit	502.80	-0.59 %	K V
CieFinRichemont	139.55	-0.99 %	K V
Swiss Re	133.25	-1.15 %	K V
Zurich Insur Gr	540.00	-1.32 %	K V
Kuehne+Nagel Int	203.00	-2.12 %	K V

Nachrichten zu Cannabics Pharmaceuticals

Aktien Top/Flop

Meistgelesene Nachrichten